Unlock instant, AI-driven research and patent intelligence for your innovation.

siRNA for inhibiting expression of FABP4 target gene and application of siRNA

A FABP4, gene expression technology, applied in the direction of DNA / RNA fragments, retroRNA virus, application, etc., can solve difficult gene silencing and other problems, achieve the effect of increasing HDL-C level and reducing plaque formation

Inactive Publication Date: 2019-11-12
CHINA PHARM UNIV
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although siRNA can specifically inhibit gene expression, siRNA in cells is easily degraded, making it difficult to achieve stable gene silencing

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • siRNA for inhibiting expression of FABP4 target gene and application of siRNA
  • siRNA for inhibiting expression of FABP4 target gene and application of siRNA
  • siRNA for inhibiting expression of FABP4 target gene and application of siRNA

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Example 1 Design and synthesis of siRNA targeting human, monkey and golden hamster FABP4

[0041] The FABP4 mRNA sequences of humans, golden hamsters and monkeys were obtained from Genebank by bioinformatics methods (RefSeqIDs are: NM_001442.2; XM_013110923.1; NM_001266067.1), and DNA man (V6) software was used to find mRNA conserved region sequences. The RNA structure analysis software was used to predict the secondary structure of the FABP4 mRNA sequence, and based on the siRNA design principles, the GC content, the secondary structure of the mRNA action site, and the base preference requirements of the siRNA were comprehensively analyzed. On the basis of siRNA online design software DSIR design, we further searched for suitable siRNA target sequences, and preliminarily screened out 4 pairs of siRNA sequences. Then use the BLAST software provided by NCBI GeneBank to select the transcript reference sequence database (Transcript Reference Sequences), and perform homolog...

Embodiment 2

[0058] Example 2 Screening of siRNA targeting FABP4 in humans, monkeys, and golden hamsters

[0059] 1. Resuscitate human mononuclear THP-1 cells, and culture them completely with RPMI-1640 containing 10% FBS. Based on a 37°C, 5% CO2 cell incubator, observe under a microscope that they are in a suspended state, and cultivate until the confluence reaches about 80%. Passaging at a ratio of 1:3. Add PMA to the passaged cell suspension to 100nM, inoculate in 6-well plate (10 5 cells / well), add 2mL RPMI-1640 complete medium to each well, culture at 37°C, 5% CO2 for 24h, and observe the cells in an adherent state under an inverted microscope, confirming that THP-1 cells have been induced to differentiate into macrophages.

[0060] 2. Use Lipofectamine 3000 to transfect 50nM siNC or siFABP4-144 or siFABP4-149 or siFABP4-150 or siFABP4-151 into the above induced differentiated human macrophages. After 72 hours of transfection, detect the expression of FABP4 protein in the cells by We...

Embodiment 3

[0061] Example 3 siFABP4-144 inhibits the expression and secretion of inflammatory factors downstream of human macrophage FABP4

[0062] After Lipofectamine 3000 transfected human macrophages with siFABP4-144 (5, 10, 30, 50, 100 nM) for 72 hours, Western blot and ELISA were used to detect the expression and secretion of FABP4 downstream inflammatory factor proteins in the cells, respectively. The results showed that siFABP4-144 dose-dependently inhibited the expression and secretion of FABP4 downstream inflammatory factors IL-6, IL-1β and TNF-α protein, while reducing the secretion of MCP-1 protein ( figure 2 A and B shown).

[0063] Human macrophages were transfected with 50 nM siFABP4-144, and after 24, 48, and 72 hours, Western blot and ELISA were used to detect the expression and secretion of inflammatory factor proteins downstream of FABP4 in the cells, respectively. The results showed that siFABP4-144 time-dependently inhibited the expression and secretion of FABP4 dow...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention provides siRNA for specifically and efficiently inhibiting expression of fatty acid binding protein 4 (FABP4) target gene and application of the siRNA. The siRNA can be chemically synthesized and constructed into corresponding recombinant viruses such as lentivirus LV-shFABP4 according to sequence of the siRNA. The siRNA or virus can effectively inhibit expression of FABP4 and downstream inflammatory factors IL-6, IL-1beta and TNF-alpha protein thereof and secretion of MCP-1 after being transfected into human or mouse macrophages. The lentivirus can significantly inhibit expression and secretion of FABP4 and downstream inflammatory factors in aorta tissue after being into ApoE<-1-> mice by tail vein injection, effectively inhibit formation of foam cells and atherosclerotic plaques and significantly increase HDL-C level in serum. The siRNA or recombinant virus or modification substance thereof can be used for preventing and / or treating diseases such as hyperlipidemia, atherosclerosis, cardiovascular and cerebrovascular diseases, obesity and diabetes related to FABP4 targets.

Description

technical field [0001] The invention belongs to biomedical technology, and in particular relates to an siRNA for inhibiting the expression of fatty acid binding protein 4 (FABP4) and its preparation for preventing and / or treating diseases such as hyperlipidemia, atherosclerosis, cardiovascular and cerebrovascular diseases, obesity and diabetes. application in medicine. Background technique [0002] Fatty acid binding proteins (FABPs) are a series of lipid chaperone proteins whose central cavity can bind long-chain fatty acids and other hydrophobic ligands. Adipocyte-type fatty acid binding protein (FABP4) is one of the members of intracellular FABPs family, with a molecular weight of 15kDa, and is highly expressed in adipocytes and macrophages. Early studies found that the basic functions of FABP4 include reversibly binding saturated and unsaturated long-chain fatty acids in a non-covalent manner to promote the metabolism and transport of fatty acids (Coe NR & Bernlohr DA. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113C12N15/867C12N7/01A61K31/713A61P3/06A61P9/12A61P9/00A61P3/04A61P3/10
CPCC12N15/113C12N15/86C12N7/00A61K31/713A61P3/06A61P9/12A61P9/00A61P3/04A61P3/10C12N2310/14C12N2740/15021C12N2740/15043C12N2750/14121C12N2750/14143
Inventor 谭树华许雅琼高洁王维
Owner CHINA PHARM UNIV